Coronary disease & ACS

Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome

Eur Heart JPublished Prospective observational cohort study

Authors' conclusion

The externally validated machine learning-based model, exclusively utilizing features from the 12-lead electrocardiogram, outperformed the HEART score in stratifying the mortality risk of patients with acute chest pain.

Study context

Population
Consecutive, non-traumatic patients with chest pain (suspected ACS)external testing cohort N = 3095
Participants
4,015 participants
Exposure
ECG feature-based machine learning model vs HEART score
Outcome
All-cause mortality
Follow-up
Median 3.05 years (IQR 1.75-5.32)
Methodological detailsexternal validation cohort
  • External validation cohort

Main finding

As reported in the abstract

All-cause mortality risk stratification
GroupSensitivityNPV
ML model85.9%93.4%
HEART score75.0%89.0%

Sensitivity

ML model85.9%
HEART score75.0%

NPV

ML model93.4%
HEART score89.0%
Mortality rate (derivation cohort)
20.3%
ML risk groups separated low-, moderate- and high-risk (log-rank test statistic = 121.14)
P < 0.001
ML model reduced rate of missed events vs HEART score
>90%

Observational data: associations, not effects.

Further findings

OutcomeOR (CI)
Mortality by ML risk group, external testing cohort · 30 daysModerate riskvs Low risk3.62 (1.35–9.74)
Mortality by ML risk group, external testing cohort · 30 daysHigh riskvs Low risk6.12 (2.38–15.75)
Mortality by ML risk group, external testing cohort — 30-day mortality, external cohort
3.5%
  • Mortality by ML risk group, external testing cohort: independent external testing cohort (N = 3095)

Original publication

Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome. Eur Heart J. Published 13 January 2025. doi:10.1093/eurheartj/ehae880

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.